1 Min Read
Oct 26 (Reuters) - Nanostring Technologies Inc:
* Nanostring and NSABP foundation enter into agreement to study immunophenotypes in colorectal cancer Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.